Bimekizumab exhibited superior drug survival rates among patients with psoriasis who have previously stopped responding to at ...

The psoriasis market is experiencing steady growth, driven by rising disease prevalence, improved diagnosis rates, and ...

Patients with moderate to severe psoriasis treated with methotrexate (MTX) plus tumor necrosis factor (TNF), interleukin (IL)-17 inhibitors, or IL-23 inhibitors experienced a comparable risk of ...

Objectives: (1) To develop a clinically useful model with which dermatologists can understand the potential uses of biologic therapy for psoriasis and understand the potential differences among these ...

Early evidence indicates that biologic therapy is effective treatment for not only plaque psoriasis but also erythrodermic and generalized pustular psoriasis. After conducting a literature review of ...

Following COVID-19–related lockdown measures, preferences for the use of biologics among Japanese patients with psoriasis addressed administration route, visits, and risk of serious infections ...

Plaque psoriasis is characterized by the formation of distinct erythematous scaly patches with clear boundaries. 1 The disease results from dysregulation of the innate and adaptive immune systems and ...

A review of 10 articles finds that nearly 9% of adverse event (AE) reports with biologics used to treat psoriasis were gastrointestinal (GI)-related and suggests that the relative rate may be higher ...

Gradient-boosted decision trees and logistic regression were effective in identifying the optimal biologic therapy for psoriasis patients, according to a study. Researchers conducted a ...